Poetker David M, Toohill Robert J, Loehrl Todd A, Smith Timothy L
Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53222, USA.
Am J Rhinol. 2005 May-Jun;19(3):307-15.
The increased experience with the endoscopic approach to sinonasal inflammatory disease has resulted in the increased use of endoscopes to manage many different sinonasal pathologies.
A chart review of patients with sinonasal tumors treated with primary endoscopic management, from January, 1993 to November, 2003 was performed.
Forty patients were identified (26 men and 14 women). The mean age was 53.2 years, and the mean follow-up was 31.1 months. For benign tumors, 24 patients were identified with a mean age of 50.7 years, a mean follow-up of 17.5 months, and a recurrence rate of 4.2%. For malignant tumors, 16 patients were identified, with a mean age of 57.3 years, a mean follow-up of 51.5 months, and a recurrence rate of 31.3%. The overall survival rate was 87.5%.
Endoscopic surgical excision of selective sinonasal tumors may be an effective therapeutic modality. In some cases, adjuvant external procedures may be required based on tumor location.
鼻窦炎性疾病内镜治疗经验的增加,导致内镜在多种不同鼻窦病变管理中的应用增多。
对1993年1月至2003年11月接受原发性内镜治疗的鼻窦肿瘤患者进行病历回顾。
共确定40例患者(26例男性和14例女性)。平均年龄为53.2岁,平均随访时间为31.1个月。对于良性肿瘤,确定24例患者,平均年龄为50.7岁,平均随访时间为17.5个月,复发率为4.2%。对于恶性肿瘤,确定16例患者,平均年龄为57.3岁,平均随访时间为51.5个月,复发率为31.3%。总生存率为87.5%。
选择性鼻窦肿瘤的内镜手术切除可能是一种有效的治疗方式。在某些情况下,根据肿瘤位置可能需要辅助性外部手术。